Live
Funding 1 min read

Kvinnehelse-startup raises NOK 7.5 million in funding

Induvita raised NOK 7.5 million in a capital emission to commercialize the Vega vaginal speculum in Europe and to develop its Iola birthing catheter, with new investors Magisk Potet AS and Fan Wing AS joining existing owners.

Nordic Startup News desk Based on reporting by Shifter · Single-source report
Read original reporting ↗
Image: Shifter

Induvita, a startup focusing on women's health, has raised NOK 7.5 million through a capital emission. The funds will support the commercialization of their Vega vaginal speculum and the development of the Iola birthing catheter.

The investment includes contributions from new investors, Magisk Potet AS and Fan Wing AS, alongside existing owners. This support is crucial as Induvita seeks to bring its innovative products to the European market.

The capital raised will enable Induvita to advance their commercialization efforts and continue the development of its medical devices, an important step for the startup's future.

Reporting sources

Where this story comes from

1 reference

The facts above are grounded in the original reporting linked here. Open the publisher story for its complete context.

Shiftershifter.no
ShifterNO source · English rendering Open source

Kvinnehelse-startup raises NOK 7.5 million in funding

The available publisher preview does not add detail beyond this brief. Open the original report for its full context.

Related coverage

Story history

No reviewed connections found in the current history window.

About this history review

The link graph’s cryptographic signature was verified. This proves integrity, not the truth of every claim or complete archive coverage.

Graph updated . Only articles retained in the public archive are included.

Open technical link data
Method & transparencyHow this brief was selected and checked
Editorial priority6 / 10

Tracked

Source coverageSingle-source report

Single-source report

ConfidenceLimited

45 / 100 · one source

Source basis

Grounded in the publisher material listed below.

Confirmation

No second independent source has been matched to this story yet.

Selection

Selected for publication after relevance, freshness and editorial-quality checks.

Selection factors

  • 1 independent source
  • 1 concrete event indicator
  • editorial priority

Source monitoring: 99% recent availability · No source-health warnings. The original publisher remains the authoritative source for the full report.